31-33 Prevention of Retinopathy: One of the least-studied potential benefits of DPP-4 inhibitors is the ability to decrease blood flow and increase vasodilation, thereby preventing retinopathy in diabetic patients
The dosage chart presented here provides a framework, but the clinical nuances, specifically the titration pace, the dose ceiling, the choice of synergistic agents, and the biomarker monitoring schedule, should be individualized by a physician familiar with both the patient's metabolic history and the evolving evidence base for mitochondrial peptide therapy
All fish naturally contains traces of mercury with larger species having higher concentration
The addition of DPP-4 inhibitors to patients already treated with metformin may seem particularly attractive, since both drugs may act to enhance circulating levels of GLP-1 and thus, may have synergistic effects on incretin receptor signaling [44,45,46]